NCT05471752

Brief Summary

The general purpose of this study is characterization of tissue-resident cells derived from different musculoskeletal and/or associated connective tissues (such as cartilage, synovial membrane, synovial fluid, bone, adipose tissue and tendons), in order to identify new strategies for the treatment of degenerative and inflammatory musculoskeletal disorders. Cells isolated from different tissue sources will be compared with each other by phenotypic and functional characterization, following culture and treatment with inflammatory elements, drugs and orthobiologics. Moreover, with the aim to assess predictive markers of therapeutic success, a correlation study of the content and properties of the cells isolated from different types of tissue with the clinical profile of the enrolled patients will be conducted.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
742

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started May 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
May 2022May 2027

Study Start

First participant enrolled

May 11, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 15, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 25, 2022

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 11, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2027

Last Updated

July 25, 2022

Status Verified

July 1, 2022

Enrollment Period

5 years

First QC Date

July 15, 2022

Last Update Submit

July 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation beetween patients' age and cell yield

    The primary outcome of the study will be to identify possible correlations between the cellular yields and patients age. The data from different tissue sources will be analyzed to assess whether the changes are tissue-specific.

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

males and females pateints, being ≥18 years old, undergoing elective surgery at IRCCS Istituto Ortopedico Galeazzi among which joint surgery (including hip or knee replacement), or anterior cruciate ligament (ACL) reconstruction or rotator cuff repair

You may qualify if:

  • males and females
  • years old
  • patients undergoing elective surgery at IRCCS Istituto Ortopedico Galeazzi among which joint surgery (including hip or knee replacement), or anterior cruciate ligament (ACL) reconstruction or rotator cuff repair

You may not qualify if:

  • age \< 18 years old
  • patients unable to sign the Informed Consent
  • positivity to virological test (HIV, HCV, HBV, TPHA)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, 20161, Italy

RECRUITING

MeSH Terms

Conditions

Musculoskeletal Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2022

First Posted

July 25, 2022

Study Start

May 11, 2022

Primary Completion (Estimated)

May 11, 2027

Study Completion (Estimated)

May 11, 2027

Last Updated

July 25, 2022

Record last verified: 2022-07

Locations